Stock Track | 180 Life Sciences Plummets 30% on $500 Million Stock Offering Announcement

Stock Track08-14

Shares of 180 Life Sciences Corp (ATNF) plunged 30% in pre-market trading on Thursday following the company's announcement of a significant stock offering. The biotechnology firm entered into a sales agreement that could potentially dilute existing shareholders' stakes, triggering a sharp sell-off.

According to a SEC filing, 180 Life Sciences has established a sales agreement with Clear Street LLC, allowing the company to offer and sell up to $500 million worth of its common stock. The shares may be sold through negotiated transactions or as "at the market offerings," with Clear Street LLC set to receive up to 3.0% of the gross sales price per share as compensation.

While the company has not specified the total number of shares to be offered or their price, the magnitude of the potential offering relative to 180 Life Sciences' market capitalization has spooked investors. Such large offerings are often viewed negatively by the market as they can significantly dilute the value of existing shares. The move suggests that the company is seeking substantial capital, possibly for research and development or to strengthen its financial position, but at the cost of shareholder value in the short term.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107834517?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-14 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107834517","market":"nz","top_or_hot":-1,"title":"Stock Track | 180 Life Sciences Plummets 30% on $500 Million Stock Offering Announcement","media":"Stock Track","content":"<p>Shares of 180 Life Sciences Corp (ATNF) plunged 30% in pre-market trading on Thursday following the company's announcement of a significant stock offering. The biotechnology firm entered into a sales agreement that could potentially dilute existing shareholders' stakes, triggering a sharp sell-off.</p>\n\n<p>According to a SEC filing, 180 Life Sciences has established a sales agreement with Clear Street LLC, allowing the company to offer and sell up to $500 million worth of its common stock. The shares may be sold through negotiated transactions or as \"at the market offerings,\" with Clear Street LLC set to receive up to 3.0% of the gross sales price per share as compensation.</p>\n\n<p>While the company has not specified the total number of shares to be offered or their price, the magnitude of the potential offering relative to 180 Life Sciences' market capitalization has spooked investors. Such large offerings are often viewed negatively by the market as they can significantly dilute the value of existing shares. The move suggests that the company is seeking substantial capital, possibly for research and development or to strengthen its financial position, but at the cost of shareholder value in the short term.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 180 Life Sciences Plummets 30% on $500 Million Stock Offering Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 180 Life Sciences Plummets 30% on $500 Million Stock Offering Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-14 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of 180 Life Sciences Corp (ATNF) plunged 30% in pre-market trading on Thursday following the company's announcement of a significant stock offering. The biotechnology firm entered into a sales agreement that could potentially dilute existing shareholders' stakes, triggering a sharp sell-off.</p>\n\n<p>According to a SEC filing, 180 Life Sciences has established a sales agreement with Clear Street LLC, allowing the company to offer and sell up to $500 million worth of its common stock. The shares may be sold through negotiated transactions or as \"at the market offerings,\" with Clear Street LLC set to receive up to 3.0% of the gross sales price per share as compensation.</p>\n\n<p>While the company has not specified the total number of shares to be offered or their price, the magnitude of the potential offering relative to 180 Life Sciences' market capitalization has spooked investors. Such large offerings are often viewed negatively by the market as they can significantly dilute the value of existing shares. The move suggests that the company is seeking substantial capital, possibly for research and development or to strengthen its financial position, but at the cost of shareholder value in the short term.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ETHZ","symbol_name":"ETHZilla Corporation","start_time":0,"source_url":"","article_id":"1107834517","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107834517","pubTimestamp":1755178542,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of 180 Life Sciences Corp (ATNF) plunged 30% in pre-market trading on Thursday following the company's announcement of a significant stock offering. The biotechnology firm entered into a sales...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ETHZ":"ETHZilla Corporation"},"translate_title":"股票追踪|180 Life Sciences发布5亿美元股票发行公告暴跌30%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ETHZ":1,"ATNF":1},"content_text":"Shares of 180 Life Sciences Corp (ATNF) plunged 30% in pre-market trading on Thursday following the company's announcement of a significant stock offering. The biotechnology firm entered into a sales agreement that could potentially dilute existing shareholders' stakes, triggering a sharp sell-off.\nAccording to a SEC filing, 180 Life Sciences has established a sales agreement with Clear Street LLC, allowing the company to offer and sell up to $500 million worth of its common stock. The shares may be sold through negotiated transactions or as \"at the market offerings,\" with Clear Street LLC set to receive up to 3.0% of the gross sales price per share as compensation.\nWhile the company has not specified the total number of shares to be offered or their price, the magnitude of the potential offering relative to 180 Life Sciences' market capitalization has spooked investors. Such large offerings are often viewed negatively by the market as they can significantly dilute the value of existing shares. The move suggests that the company is seeking substantial capital, possibly for research and development or to strengthen its financial position, but at the cost of shareholder value in the short term.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107834517","isCrawlerRequest":true}